Skip to main content

Animations

MJFF Publications

5551 - 5575 of 9145 Results
Title
Year
  • Year
  • 2015
  • 2014
  • 2019
  • 2019
  • 2018
  • 2018
  • 2017
  • 2018
  • 2018
  • 2022
  • 2013
  • 2013
  • 2013
  • 2019
  • 2018
  • 2020
  • 2021
  • 1967
  • 2019
  • 2020
  • 2007
  • 2019
  • 2019
  • 2019
  • 2020
  • Summary Details
    OPEN
    Title: Feasibility of Virtual Research Visits in Fox Trial Finder
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-150549
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Overcoming obstacles to repurposing for neurodegenerative disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.76
    Citation Count: 62
  • Summary Details
    OPEN
    Title: The Parkinson's disease e‐diary: Developing a clinical and research tool for the digital age
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27673
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/59758
    Citation Count: 56
  • Summary Details
    OPEN
    Title: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-181471
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/jnc.14569
    Citation Count: 56
  • Summary Details
    OPEN
    Title: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s Disease
    Journal Name: Biomarkers in Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/bmm-2016-0366
    Citation Count: 52
  • Foundations for a Patient-Reported Natural History of Parkinson Disease: Cross sectional Analysis of the MJFF Fox Insight (FI) Platform (P2.056)
    2018
    Summary Details
    RESTRICTED
    Title: Foundations for a Patient-Reported Natural History of Parkinson Disease: Cross sectional Analysis of the MJFF Fox Insight (FI) Platform (P2.056)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p2.056
    Citation Count: 2
  • Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)
    2018
    Summary Details
    RESTRICTED
    Title: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p3.048
    Citation Count: 4
  • Incidence of Parkinson Disease in North America (P1-1.Virtual)
    2022
    Summary Details
    RESTRICTED
    Title: Incidence of Parkinson Disease in North America (P1-1.Virtual)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.98.18_supplement.2665
    Citation Count: 3
  • Announcing a New Continuing Medical Education Course
    2013
    Summary Details
    RESTRICTED
    Title: Announcing a New Continuing Medical Education Course
    Journal Name: Cognitive and Behavioral Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/wnn.0b013e31829af2fb
    Citation Count: 1
  • The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)
    2013
    Summary Details
    RESTRICTED
    Title: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049
    Citation Count: 2
  • P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease
    2013
    Summary Details
    RESTRICTED
    Title: P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease
    Journal Name: Neuromuscular Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nmd.2013.06.684
    Citation Count: 1
  • NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)
    2019
    Summary Details
    RESTRICTED
    Title: NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-035
    Citation Count: 2
  • At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease
    2018
    Summary Details
    OPEN
    Title: At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27310
    Citation Count: 1
  • Validation of Fox Insight Cohort via Virtual Research Visits (4749)
    2020
    Summary Details
    RESTRICTED
    Title: Validation of Fox Insight Cohort via Virtual Research Visits (4749)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4749
    Citation Count: 1
  • Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
    2021
    Summary Details
    RESTRICTED
    Title: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities
    Journal Name: Physiology News
    Publisher: The Physiological Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.36866/pn.123.32
    Citation Count: 1
  • The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA
    1967
    Summary Details
    RESTRICTED
    Title: The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA
    Journal Name: Arthritis & Rheumatism
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/art.1780100105
    Citation Count: 45
  • Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)
    2019
    Summary Details
    RESTRICTED
    Title: Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-010
    Citation Count: 1
  • Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    2020
    Summary Details
    RESTRICTED
    Title: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418
    Citation Count: 1
  • Special focus section: Gene therapy for Parkinson's disease
    2007
    Summary Details
    RESTRICTED
    Title: Special focus section: Gene therapy for Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2007.09.006
    Citation Count: 6
  • Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)
    2019
    Summary Details
    RESTRICTED
    Title: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-011
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience Data
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088
    Citation Count: 0
  • Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)
    2019
    Summary Details
    RESTRICTED
    Title: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Creating a patient‐centered guide to navigating cognitive change in Parkinson’s disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.041115
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.